Addimmune™

📍 Rockville, United States🗓 Founded 2023👥 4 employees💰 Last funded Jun 2023
Biotechnology Research🌐 addimmune.com
Website LinkedIn
At Addimmune, our mission is to deliver the world’s first functional cure for HIV. Using viral vector delivery, we are seeking to give the immune system the tools it needs to resist and ultimately clear the virus.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2023
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Germany
1
Frequently asked questions
Who invested in Addimmune™?
Addimmune™ has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Addimmune™ last raise funding?
The most recent investment in Addimmune™ recorded on gritt.io was in June 2023.
When was Addimmune™ founded?
Addimmune™ was founded in 2023.
What industry is Addimmune™ in?
Addimmune™ operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Addimmune™ based?
Addimmune™ is headquartered in Rockville, United States.